| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 4 securities · may seek to influence control | ||||||
|
Cocrystal Pharma, Inc.
13D/A
COCP · 19188J409
|
13.9% |
8/7/2026
Event 8/3/2026
|
||||
| Phillip Frost, M.D. | 13.9% | |||||
| Frost Gamma Investments Trust | 13.5% | |||||
|
Opko Health, Inc.
13D/A
OPK · 68375N103
|
34.1% |
7/1/2026
Event 6/29/2026
|
||||
| Frost Phillip MD Et Al | 34.1% | |||||
| Frost Gamma Investments Trust | 29.0% | |||||
| Frost Nevada Investments Trust | 4.0% | |||||
|
Fluent, Inc.
13D/A
FLNT · 34380C201
|
24.7% |
1/28/2026
Event 12/22/2025
|
||||
| Phillip Frost, M.D. | 24.7% | |||||
| Frost Gamma Investments Trust | 24.7% | |||||
|
Nocopi Technologies Inc/MD/
13D/A
NNUP · 655213106
|
13.6% |
6/11/2025
Event 6/6/2025
|
||||
| Phillip Frost, M.D. | 13.6% | |||||
| Frost Gamma Investments Trust | 13.6% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
Safe Pro Group Inc.
13G
SPAI · 78642D101
|
9.8% |
9/14/2026
Event 9/9/2026
|
||||
| Phillip Frost, M.D. | 9.8% | |||||
| Frost Gamma Investments Trust | 9.8% | |||||
|
Douglas Elliman Inc.
13G/A
DOUG · 25961D105
|
8.6% |
2/11/2025
Event 1/1/2025
|
||||
| Phillip Frost, M.D. | 8.6% | |||||
| Frost Gamma Investments Trust | 8.6% | |||||
| Patricia Frost | 0.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.